The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 20091022)

Published in Diabetologia on November 29, 2009

Authors

K Müssig1, M Heni, C Thamer, K Kantartzis, F Machicao, N Stefan, A Fritsche, H-U Häring, H Staiger

Author Affiliations

1: Department of Internal Medicine IV (Endocrinology, Diabetology, Angiology, Nephrology, and Clinical Chemistry), University Hospital of Tübingen, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.

Articles by these authors

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia (2007) 3.34

Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia (2008) 2.57

Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia (2007) 2.16

Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes (2008) 1.96

The effects of skin temperature and testing site on blood glucose measurements taken by a modern blood glucose monitoring device. Diabetes Technol Ther (2005) 1.82

Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab (2010) 1.76

Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia (2008) 1.69

Medical antihyperglycaemic treatment of type 2 diabetes mellitus: update of the evidence-based guideline of the German Diabetes Association. Exp Clin Endocrinol Diabetes (2009) 1.65

Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia (2005) 1.64

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut (2008) 1.53

The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53

The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia (2010) 1.45

The effect of age on complications in women undergoing minimally invasive sacral colpopexy. Int Urogynecol J (2014) 1.45

Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care (2001) 1.44

[MODY diabetes]. Dtsch Med Wochenschr (1992) 1.38

[68-year-old female patient with dyspnea and hypokalemic hypertension]. Internist (Berl) (2007) 1.38

Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia (2007) 1.28

A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia (2009) 1.27

Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia (2012) 1.24

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine. Diabetes Obes Metab (2010) 1.23

Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest (2007) 1.23

Type 2 diabetes mellitus and risk of malignancy: is there a strategy to identify a subphenotype of patients with increased susceptibility to endogenous and exogenous hyperinsulinism? Diabet Med (2011) 1.22

Insulin rapidly stimulates phosphorylation of a 46-kDa membrane protein on tyrosine residues as well as phosphorylation of several soluble proteins in intact fat cells. Proc Natl Acad Sci U S A (1987) 1.22

Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Diabetologia (2000) 1.19

Tissue selectivity of insulin detemir action in vivo. Diabetologia (2006) 1.15

Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin receptor kinase from rat adipocytes. J Biol Chem (1986) 1.15

Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia (2010) 1.14

Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia (2008) 1.12

Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study. MAGMA (2005) 1.11

[Indicators of incipient atherosclerosis: demonstration of endothelial dysfunction with high-resolution ultrasound]. Ultraschall Med (2003) 1.08

Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res (2005) 1.07

A functioning adrenocortical hemangioma. J Urol (1996) 1.06

[Hypercalcemic crisis due to primary hyperparathyroidism]. Dtsch Med Wochenschr (2008) 1.06

Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes (2001) 1.05

Body adiposity index, body fat content and incidence of type 2 diabetes. Diabetologia (2012) 1.05

Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells. Horm Metab Res (2007) 1.05

Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochem J (1986) 1.03

Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans. Diabetes (2001) 1.02

Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia (2012) 1.01

A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest (2000) 1.01

Necrotizing fasciitis caused by unencapsulated Haemophilus influenzae. Clin Infect Dis (1997) 1.01

Phosphorylation--dephosphorylation of purified insulin receptor from human placenta. Effect of insulin. FEBS Lett (1982) 0.99

Further evidence for a two-step model of glucose-transport regulation. Inositol phosphate-oligosaccharides regulate glucose-carrier activity. Biochem J (1989) 0.99

Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocrinol Metab (2005) 0.99

Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity. Diabetologia (2009) 0.98

Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance. Diabetologia (2002) 0.97